Logo

Bioké Inks Distribution Deal for Advanced Cell Diagnostics Products in Benelux Region

Jun 07, 2012 | staff reporter

NEW YORK (GenomeWeb News) – Bioké and Advanced Cell Diagnostics today announced a distribution deal covering the Benelux region.

Under the terms of the deal, which took effect on May 1, Bioké will promote, sell, and provide technical and customer support for ACD products in Belgium, Luxembourg, and the Netherlands. Financial and other terms were not disclosed.

ACD, based in Hayward, Calif., is a molecular pathology company. Its products and services are based on its RNAscope technology, an in situ hybridization platform for detecting and quantifying RNA biomarkers at single-molecule sensitivity. It offers single and multiplex readouts in chromogenic and fluorescent formats.

Bioké, headquartered in Leiden, the Netherlands, sells life science and diagnostics products.

Filed under

Diagnostics
Business News
distribution agreement
Bioke
Advanced Cell Diagnostics
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.